Int J Drug Policy. 2021 Dec;98:103348. doi: 10.1016/j.drugpo.2021.103348. Epub 2021 Jun 14.
People who use drugs, or who have in the past, often report that doctors and/or treatment providers devalue, or are unwilling to believe their claims in regards to substance use issues, in particular the presence and severity of withdrawal. In the case of benzodiazepine withdrawal this can not only lead to significant discomfort, frustration, and trauma for patients, but can lead to serious medical problems. This commentary uses the authors' recent first-person experience with a disbelieving doctor in order to illustrate the lack of value often given to the claims and narratives of people with lived substance use experience. I outline some of the potential problems with this approach, including the effects on patients themselves and the loss of an important source of evidence-based knowledge. It also discusses potential risks associated with the recent increase in benzodiazepine prescription due to Covid-19 and offers suggestions for improving treatment outcomes.
使用毒品或有过吸毒史的人经常报告说，医生和/或治疗提供者贬低或不愿意相信他们在药物使用问题上的说法，尤其是在戒断的存在和严重程度方面。在苯二氮䓬类药物戒断的情况下，这不仅会给患者带来严重的不适、沮丧和创伤，还会导致严重的医疗问题。本评论使用作者最近的第一人称经历来说明，医生经常不重视有药物使用经验的人的说法和叙述。我概述了这种方法可能存在的一些问题，包括对患者自身的影响以及失去基于证据的重要知识来源。它还讨论了由于 COVID-19 导致苯二氮䓬类药物处方增加所带来的潜在风险，并提出了改善治疗结果的建议。
